Association of [³H]-Imipramine and [³H]-Paroxetine Binding with the 5Ht Transporter in Brain and Platelets Relevance to Studies in Depression

References

• Raisman R., Briley M. S., Langer S. Z. Specific tricyclic antidepressant binding sites in rat brain. Nature 1979; 281: 148–150
   Google Scholar
• Langer S. Z., Moret C., Raisman R., Dubocovich M. L., Briley M. S. High-affinity 3H-imipramine binding in rat hypothalamus is associated with the uptake of serotonin but not norepinephrine. Science 1980; 210: 1133–1135
   PubMed Web of Science ®Google Scholar
• Langer S. Z., Briley M. S., Raisman R., Henry J. F., Morselli P. L. Specific 3H-impramine binding in human platelets: influence of age and sex. Naunyn-Schmiedeberg's Arch. Pharmacol. 1980; 313: 189–194
   Google Scholar
• Langer S. Z., Javoy-Agid F., Raisman R., Briley M. S., Agid Y. Distribution of specific high-affinity binding sites for Imipramine in human brain. J. Neurochem. 1981; 37: 267–271
   PubMed Web of Science ®Google Scholar
• Langer S. Z., Zarifian E., Briley M. S., Raisman R., Sechter D. High-affinity binding of 3H-imipramine in brain and platelets and its relevance to the biochemistry of affective disorders. Life Sci. 1981; 29: 211–218
   PubMed Web of Science ®Google Scholar
• Segonzac A., Raisman R., Tateishi T., Schoemaker H., Hicks P. E., Langer S. Z. Tryptamine, a substrate for the serotonin transporter in human platelets, modifies the dissociation kinetics of [3H]imipramine binding: possible allosteric interaction. J. Neurochem. 1985; 44: 349–356
   PubMed Web of Science ®Google Scholar
• Langer S. Z., Raisman R. Binding of [3H]-imipramine and [3H]-desipramane as biochemical tools for studies in depression. Neuropharmacology 1983; 22: 407–413
   PubMed Web of Science ®Google Scholar
• Langer S. Z., Raisman R., Tahraoui L., Scatton B., Niddam R., Lee C. R., Claustre Y. Substituted tetrahydro-β-carbolines are possible candidates as endogenous ligand of the [3H]imipramine recognition site. Eur. J. Pharmacol. 1984; 98: 153–154
   PubMed Web of Science ®Google Scholar
• Barbaccia M. L., Gandolfi O., Chuang D. M., Costa E. Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites. Proc. Natl. Acad. Sci. U.S.A. 1983; 80: 5134–5138
   PubMed Web of Science ®Google Scholar
• Barbaccia M. L., Costa E. Autocoids for drug receptors : a new approach in a drug development. Ann. N.Y. Acad. Sci. 1984; 430: 103–114
   PubMed Web of Science ®Google Scholar
• Lewis D. A., McChesney C. Tritiated imipramine binding distinguishes among subtypes of depression. Arch. Gen. Psychiatry 1985; 42: 485–488
   PubMed Web of Science ®Google Scholar
• Poirier M. F., Benkelfat C., Loo H., Sechter D., Zarifian E., Galzin A. M., Langer S. Z. Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors. Psychopharmacology 1986; 89: 456–461
   PubMed Web of Science ®Google Scholar
• Perry E. K., Marshall E. F., Blessed G., Tomlinson B. E., Perry R. H. Decreased imipramine binding in the brain of patients with depressive illness. Br. J. Psychiatry 1983; 142: 188–192
   Google Scholar
• Stanley M., Virgilio S., Gershon S. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 1982; 216: 1337–1339
   Google Scholar
• Raisman R., Briley M. S., Langer S. Z. Specific tricyclic antidepressant binding sites in rat brain characterised by high-affinity [3H]-imipramine binding. Eur. J. Pharmacol. 1980; 61: 373–380
   PubMed Web of Science ®Google Scholar
• Langer S. Z., Zarifian E., Briley M. S., Raisman R., Sechter D. High-affinity 3H-imipramine binding: a new biological marker in depression. Pharmacopsychiatry. 1982; 15: 3–10
   Google Scholar
• Raisman R., Briley M. S., Langer S. Z. High affinity 3H-imipramine binding in rat cerebral cortex. Eur. J. Pharmacol. 1979; 54: 307–308
   PubMed Web of Science ®Google Scholar
• Briley M. S., Raisman R., Langer S. Z. Human platelets possess high-affinity binding sites for 3H-imipramine. Eur. J. Pharmacol. 1979; 58: 347–348
   PubMed Web of Science ®Google Scholar
• Langer S. Z., Briley M. S. High affinity 3H-imipramine binding: a new biological tool for studies in depression. Trends Neurosci. 1981; 4: 28–31
   Web of Science ®Google Scholar
• Sette M., Briley M. S., Langer S. Z. Complex inhibition of 3H-imipramine binding by serotonin and non-tricyclic serotonin uptake blockers. J. Neurochem. 1983; 40: 622–628
   PubMed Web of Science ®Google Scholar
• Brunello M., Chuang D., Costa E. Different synaptic localizations of mianserin and imipramine binding sites. Science 1982; 215: 1112–1115
   Google Scholar
• Gross G., GÖThert M., Ender H. C., SchÜMann H. J. 3H-imipramine binding sites in the rat brain : selective localization on serotoninergic neurons. Naunyn-Schmiedeberg's Arch. Pharmacol. 1981; 317: 310–314
   Google Scholar
• Paul S. M., Rehavi M., Rice K. C., Ittah Y., Skolnick P. Does high-affinity [3H]-imipramine binding label serotonin reuptake sites in brain and platelet. Life Sci. 1981; 28: 2753–2760
   PubMed Web of Science ®Google Scholar
• Sette M., Raisman R., Briley M. S., Langer S. Z. Localization of tricyclic antidepressant binding sites on serotonin nerve terminals in rat hypothalamus. J. Neurochem. 1981; 37: 40–42
   PubMed Web of Science ®Google Scholar
• Habert E., Graham D., Tahraoui L., Claustre Y., Langer S. Z. Characterization of [3H]paroxetine binding to rat cortical membranes. Eur. J. Pharmacol. 1985; 118: 107–114
   PubMed Web of Science ®Google Scholar
• Hall H., Ross R., Ogren S. O., Gawell L. Binding of a specific 5HT uptake inhibitor, 3H-norzimelidine, to rat brain homogenates. Eur. J. Pharmacol. 1982; 80: 281–282
   PubMed Web of Science ®Google Scholar
• Schoemaker H., Langer S. Z. High affinity binding antidepressants to platelets and brain tissue. Neuromethods, A. A. Boulton, G. B. Barker, R. T. Coutts. Humana Press. 1974; vol. 6, “Analysis of Psychiatric drugs” (in press)
   Google Scholar
• Wennogle L. P., Meyerson L. R. Serotonin modulates the dissociation of [3H]-imipramine from human platelets recognition sites. Eur. J. Pharmacol. 1983; 86: 303–307
   Web of Science ®Google Scholar
• Plenge P., Mellerup E. T. Antidepressive drugs can change the affinity of [3H]-imipramine and [3H]-paroxetine binding to platelet and neuronal membranes. Eur. J. Pharmacol. 1985; 119: 1–8
   PubMed Web of Science ®Google Scholar
• Segonzac A., Tateishi T., Langer S. Z. Saturable uptake of [3H]-tryptamine in rabbit platelets is inhibited by 5-hydroxytryptamine uptake blockers. Naunyn-Schmiedeberg's Arch. Pharmacol. 1984; 328: 33–37
   Google Scholar
• Langer S. Z., Sette M., Raisman R. Association of 3H-imipramine binding with serotonin uptake and of 3H-desipramine binding with noradrenaline uptake: potential research tools in depression. Clinical Pharmacology in Psychiatry, L. Gram, et al. Macmillan Press, London 1983; 339–348
   Google Scholar
• Sette M., Ruberg M., Raisman R., Scatton B., Zivkovic B., Agid Y., Langer S. Z. [3H]-imipramine binding in subcellular fractions of the rat cerebral cortex after chemical lesion of serotoninergic neurons. Eur. J. Pharmacol. 1983; 95: 41–51
   PubMed Web of Science ®Google Scholar
• Kim S. S., Reith M. E.A. Effect of serotonin on the dissociation of high-affinity binding of [3H]-imipramine in mouse cerebral cortex. Neurosci. Lett 1986; 67: 123–128
   PubMed Web of Science ®Google Scholar
• Langer S. Z. Presynaptic regulation of the release of catecholamines. Pharmacol. Rev. 1981; 32: 337–362
   Web of Science ®Google Scholar
• Barbaccia M. L., Melloni P., Pozzi O., Costa E. [3H]Imipramine displacement and 5HT uptake inhibition by tryptoline derivatives: in rat brain 5-methoxytryptoline is not the autacoid for [3H]imipramine recognition sites. Eur. J. Pharmacol. 1986; 123: 45–52
   PubMed Web of Science ®Google Scholar
• Rehavi M., Ventura I., Sarne Y. Demonstration of endogenous “imipramine like” material in rat brain. Life Sci. 1985; 36: 687–693
   PubMed Web of Science ®Google Scholar
• Lee C. R., Galzin A. M., Taranger M. A., Langer S. Z. Pitfalls in demonstrating an endogenous ligand of imipramine recognition site. Biochem. Pharmacol.
   Google Scholar
• Angel I., Paul S. M. Inhibition of synaptosomal 5-[3H]-hydroxytryptamine uptake by endogenous factor(s) in human blood. FEBS Lett. 1984; 171: 280–284
   PubMed Web of Science ®Google Scholar
• Angel I., Goldman M. E., Skolnick P., Pisano J. J., Paul S. M. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum. Endocoids, H. Lal, F. Lalla, J. Lane. Alan R. Liss, New York 1985; 457–464
   Google Scholar
• Langer S. Z., Lee C. R., Segonzac A., Tateishi T., Esnaud H., Schoemaker H., Winblad B. Possible endocrine role of the pineal gland for 6-methoxytetrahydro-β-carboline, a putative endogenous neuromodulator of the [3H]imipramine recognition site. Eur. J. Pharmacol. 1984; 102: 379–380
   PubMed Web of Science ®Google Scholar
• Langer S. Z., Lee C. R., Schoemaker H., Segonzac A., Esnaud H. 5-methoxytryptoline and close analogs as candidates for the endogenous ligand of the 3H-imipramine recognition site. Endocoids, H. Lal, F. Labella, J. Lane. Alan R, Liss, New York 1985; 441–455
   Google Scholar
• Langer S. Z., Galzin A. M., Lee C. R., Schoemaker H. Antidepressant binding sites in brain and platelets. Antidepressants and receptor function, Ciba Foundation Symposium 123. John Wiley and Sons. 1986; 3–29
   Google Scholar
• Meyer D. C., Quay W. B. Hypothalamic and suprachiasmatic uptake of serotonin in vitro: twenty-four-hours changes in male and proestrous female rats. Endocrinology 1976; 98: 1160–1165
   Google Scholar
• Rusak B., Zucker I. Neural regulation of circadian rhythms. Physiol. Rev. 1979; 59: 449–526
   PubMed Web of Science ®Google Scholar
• Wirz-Justice A., KrÄUchi K., Morimasa T., Willener R., Feer H. Circadian rhythm of [3H]imipramine binding in the rat suprachiasmatic nuclei. Eur. J. Pharmacol. 1983; 87: 331–333
   PubMed Web of Science ®Google Scholar
• Mason R. Circadian variation in sensitivity of suprachiasmatic and lateral geniculate neurones to 5-hydroxytryptamine in the rat. J. Physiol 1986; 377: 1–13
   Google Scholar
• Modai I, Malmgren R., Asberg M., Beving H. Circadian rhythm of serotonin transport in human platelets. Psychopharmacol. 1986; 88: 493–495
   PubMed Web of Science ®Google Scholar
• Wehr T. A., Goodwin F. K. Biological rhythms and psychiatry. American Handbook of Psychiatry 2nd ed, S. Arieti. Basic Books, New York 1981; vol. 7: 46–74, Advances and New Directions
   Google Scholar
• Briley M. S., Raisman R., Arbilla S., Casadamont M., Langer S. Z. Concomitant decrease in (3H)-imipramine binding in cat brain and platelets after chronic treatment with imipramine. Eur. J. Pharmacol. 1982; 81: 305–314
   Web of Science ®Google Scholar
• Briley M. S., Langer S. Z., Raisman R., Sechter D., Zarifian E. Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science 1980; 209: 303–305
   Google Scholar
• Raisman R., Sechter D., Briley M. S., Zarifian E., Langer S. Z. High affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers. Psychopharmacology 1981; 75: 368–371
   PubMed Web of Science ®Google Scholar
• Raisman R., Briley M. S., Bouchami F., Sechter D., Zarifian E., Langer S. Z. 3H-Imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteers. Psychopharmacology 1982; 77: 332–335
   PubMed Web of Science ®Google Scholar
• Mellerup C., Plenge P., Rosenberg R. 3H-imipramine binding sites in platelets from psychiatric patients. Psychiatry Res. 1982; 7: 221–227
   PubMed Web of Science ®Google Scholar
• Friedl W., Propping P., Weck B. 3H-Imipramine binding in platelets: Influence of varying proportions of intact platelets in membrane preparations of binding. Psychopharmacol. 1983; 80: 96–99
   PubMed Web of Science ®Google Scholar
• Langer S. Z., Raisman R., Secher D., Gay C., Loo H., Zarifian E. 3H-Imipramine and 3H-desipramine in depression. Frontiers im Biochemical and Pharmacological Research in Depression, E. Usdin, et al. Raven Press, New York 1984; 113–125
   Google Scholar
• Langer S. Z., Sechter D., Loo H., Raisman R., Zarifian E. Electroconvulsive shock therapy and maximum binding of platelet 3H-imipramine binding in depression. Arch. Gen. Psychiat. 1986; 43: 949–952
   PubMed Web of Science ®Google Scholar
• Poirier M. F., Loo H., Benkelfat C., Sechter D., Zarifian E., Galzin A. M., Schoemaker H., Segonzac A., Langer S. Z. [3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatment. Eur. J. Pharmacol. 1984; 106: 629–633
   PubMed Web of Science ®Google Scholar
• Poirier M. F., Galzin A. M., Loo H., Pimoule C., Segonzac A., Benkelfat C., Sechter D., Schoemaker Zarifian E., Langer S. Z. Changes in [3H]-5-HT uptake and [3H]-imipramine binding in platelets after chlorimipramine in healthy volunteers: comparison with maprotiline and amineptine. Biol. Psychiatry 1986, in press
   Web of Science ®Google Scholar
• Braddock L. E., Cowen P. J., Eliott J. M., Fraser S., Stump K. Changes in the binding to platelets of [3H]imipramine and [3H]yohimbine in normal subjects taking amitriptyline. Neuropharmacology 1984; 23: 285–286
   PubMed Web of Science ®Google Scholar
• Suranyi-Cadotte B., Lafaille F., Schwartz G., Nair N. P.V., Quirion R. Unchanged platelet 3H-imipramine binding in normal subjects after imipramine administration. Biol. Psychiatry 1985; 20: 1237–1240
   PubMed Web of Science ®Google Scholar
• Poirier M. F., Galzin A. M., Pimoule C., Schoemaker H., Le Quan Bui K. H., Meyer P., Gay C., Loo H., Langer S. Z. Short term lithium administration to healthy volunteers produces long-lasting pronounced changes in platelet serotonin uptake, but not imipramine binding. Science, submitted
   Google Scholar
• Suranyi-Cadotte B., Wood P. L., Nair N. P.V., Schwartz G. Normalization of platelet (3H)imipramine binding in depressed patients during remission. Eur. J. Pharmacol. 1982; 85: 357–358
   PubMed Web of Science ®Google Scholar
• Suranyt-Cadotte B. E., Quirion R., McQuade P., Nair N. P.V., Schwartz G., Mosticyan S., Wood P. L. Platelet 3H-imipramine binding: a state-dependent marker in depression. Prog. Neuropsychopharmacol. Biol. Psychiat. 1984; 8: 737–741
   PubMed Web of Science ®Google Scholar
• Berrettini W. H., Nurmberg J. I., Post R. M., Gershon E. S. Platelet 3H-imipramine binding in euthymic bipolar patients. Psychiat. Res. 1982; 7: 215–219
   PubMed Web of Science ®Google Scholar
• Wirz-Justice A., Richter R. Seasonality in biochemical determinations: a source of variation and a clue to the temporal incidence of affective disorders. Psychiat. Res. 1979; 1: 53–60
   PubMed Web of Science ®Google Scholar
• Egrise D., Desmedt D., Schoutens A., Mendlewicz J. Circannual variations in the density of tritiated Imipramine binding sites on blood platelets in man. Neuropsychobiology 1983; 10: 101–102
   Google Scholar
• Whitaker P. M., Warsh J. J., Stancer H. C., Persad E., Vint C. K. Seasonal variation in platelet 3H-imipramine binding: comparable values in control and depressed populations. Psychiat. Res. 1984; 11: 127–131
   PubMed Web of Science ®Google Scholar
• Galzin A. M., Loo H., Sechter D., Langer S. Z. Lack of seasonal variation in platelet [3H]imipramine binding in humans. Biol. Psychiatry 1986; 21: 876–882
   PubMed Web of Science ®Google Scholar
• Gentsch C., Lichtsteiner M., Gastpar M., Gastpar G., Feer H. 3H-imipramine binding sites in platelets of hospitalized psychiatric patients. Psychiat. Res. 1985; 14: 177–187
   PubMed Web of Science ®Google Scholar
• Oxenkrug G. H., Prakhje I., Mikhalenka I. N. Disturbed circadian rhythm of 5-HT uptake by blood platelets in depressive psychosis. Acta Nervosa suppl. (Praha) 1978; 20: 66–67
   Google Scholar
• Sherman B. M., Pfohl B. Rhythm-related changes in pituitary-adrenal function in depression. J. Affect. Disord. 1985; 9: 55–61
   PubMed Web of Science ®Google Scholar
• Winokur G., Pfohl B., Sherman B. The relationship of historically defined subtypes of depression to ACTH and cortisol levels in depression: Preliminary study. Biol. Psychiatry 1985; 20: 751–757
   Google Scholar
• Beck-Friis J., Kjellman B. F., Aperia B., Unden F., Von Rosen D., Ljunggren J. G., Wetterberg L. Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome. Acta Psychiatr. Scand. 1985; 71: 319–330
   PubMed Web of Science ®Google Scholar
• Brown R., Kocsis J. H., Caroff S., Amsterdam J., Winokur A., Stokes P. E., Frazer A. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. Am. J. Psychiat. 1985; 142: 811–816
   PubMed Web of Science ®Google Scholar
• Poirier M. F., Benkelfat C., Galzin A. M., Langer S. Z. Platelet 3H-imipramine binding and steroid hormones serum concentrations during the menstrual cycle. Psychopharmacol. 1986; 88: 86–89
   Web of Science ®Google Scholar
• Katona C. L.E., Theodorou A. E., Missouris C. G., Bourke M. P., Horton R. W., Moncrieff D., Paykel E. S., Kelly J. S. Platelet 3H-imipramine binding in pregnancy and the puerperium. Psychiatry Res. 1985; 14: 33–37
   PubMed Web of Science ®Google Scholar
• Lewis D. A., No Yes R., Coryell W, Clancy J. Tritiated imipramine binding to platelets is decreased in patients with agoraphobia. Psychiat. Res. 1985; 16: 1–9
   PubMed Web of Science ®Google Scholar
• Norman T. R., Judd F. K., Gregory M., James R. H., Kimber N. M., McIntyre I. M., Burrows G. D. Platelet serotonin uptake in panic disorder. J. Aff. Disorders 1986; 11: 69–72
   PubMed Web of Science ®Google Scholar
• Asarch K. B., Shih J. C., Kubesar A. Decreased 3H-imipramine binding in depressed males and females. Commun. Psychopharmacol. 1980; 4: 425–432
   PubMedGoogle Scholar
• Paul S. M., Rehavi M., Skolnick P., Ballenger J. C., Goodwin F. K. Depressed patients have decreased binding of 3H-imipramine to the platelets serotonin “transporter”. Arch. Gen. Psychiatry 1981; 38: 1315–1317
   PubMed Web of Science ®Google Scholar
• Suranyi-Cadotte B. E., Gauthier S., Lafaille F., Deflores S., Dam T. V., Nair N. P.V., Quirion R. Platelet 3H-imipramine binding distinguishes depression from Alzheimer dementia. Life Sci. 1985; 37: 2305–2311
   PubMed Web of Science ®Google Scholar
• Suranyi-Cadotte B. E., Quirion R., Nair N. P.V., Lafaille F., Schwartz G. Imipramine treatment differentially affects platelets 3H-imipramine binding and serotonin uptake in depressed patients. Life Sci. 1985; 36: 795–799
   PubMed Web of Science ®Google Scholar
• Schneider L. S., Severson J. A., Sloane R. B. Platelet 3H-imipramine binding in depressed elderly patients. Biol. Psychiat. 1985; 20: 1232–1234
   PubMed Web of Science ®Google Scholar
• Tanimoto K., Maeda K., Terada T. Alteration of platelet [3H]imipramine binding in mildly depressed patients correlates with disease severity. Biol. Psychiatry 1985; 20: 329–352
   PubMed Web of Science ®Google Scholar
• WÄGner A., Aberg-Wistedt A., Asberg M., Ekqvist B., MÄRtensson B., Montero D. Lower 3H-imipramine binding in platelets from untreated depressed patients compared to healthy controls. Psychiat. Res. 1985; 16: 131–139
   PubMed Web of Science ®Google Scholar
• Baron M., Barkai A., Gruen R., Peselow M. D., Fieve R. R., Quitkin F. Platelet 3H-imipramine binding in affective disorders: trait versus state characteristics. Am. J. Psychiatry 1986; 143: 711–717
   PubMed Web of Science ®Google Scholar
• Baron M., Barkai A., Gruen R., Kowalik S., Quitkin F. 3H-Imipramine platelet binding sites in unipolar depression. Biol. Psychiatry 1983; 18: 1403–1409
   PubMed Web of Science ®Google Scholar
• Tang S. W., Morris J. M. Variation in human platelet 3H-imipramine binding. Psychiat. Res. 1985; 16: 141–146
   PubMed Web of Science ®Google Scholar
• Hrdina P. D., Lapierre Y. D., Horn E. R., Bakish D. Platelet 3H-imipramine binding: a possible predictor of response to antidepressant treatment. Prog. Neuro-Psychopharmacol. Biol. Psychlat. 1985; 9: 619–623
   PubMed Web of Science ®Google Scholar
• Muscettola G., Di Lauro A., Gianini C. P. Platelet 3H-imipramine binding in bipolar patients. Psychiatry Res. 1986; 18: 343–353
   PubMed Web of Science ®Google Scholar
• Carstens M. E., Engelbrecht A. H., Russel V. A., Aalbers C., Gagiano C. A., Chalton D. O., Taljaard J. J.F. Imipramine binding sites on platelets of patients with major depressive disorder. Psychiatry Res. 1986; 18: 333–342
   Google Scholar
• Kamal L. A., Raisman R., Meyer P., Langer S. Z. Reduced Vmax of 3H-serotonin uptake but unchanged 3H-imipramine binding in the platelets of untreated hypertensive subjects. Life Sci. 1984; 34: 2083–2088
   PubMed Web of Science ®Google Scholar
• Ahtee L., Briley M. S., Raisman R., Lebrec D., Langer S. Z. Reduced uptake of serotonin but unchanged 3H-imipramine binding in the platelets from cirrhotic patients. Life Sci. 1981; 29: 2323–2329
   PubMed Web of Science ®Google Scholar
• Anderson G. M., Minderaa R. B., Van Benthem P. P.G., Volkmar R., Cohen D. J. Platelet imipramine binding in autistic subjects. Psychiat. Res. 1984; 11: 133–141
   PubMed Web of Science ®Google Scholar
• Insel T. R., Mueller E. A., Alterman I., Linnoila M., Murphy D. L. Obsessive compulsive disorder and serotonin: is there a connection? Biol. Psychiat. 1985; 20: 1174–1188
   Google Scholar
• Weizman A., Carmi M., Hermesh H., Shahar A., Apter A., Tyano S., Rehavi M. High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients. Am. J. Psychiat. 1986; 143: 335–339
   PubMed Web of Science ®Google Scholar
• Weizman R., Carmi M., Tyano S., Apter A., Rehavi M. High affinity [3H]imipramine binding and serotonin uptake to platelets of adolescent females suffering from anorexia nervosa. Life Sci. 1986; 38: 1235–1242
   PubMed Web of Science ®Google Scholar
• Weizman R., Carel C., Tyano S., Rehavi M. Decreased high affinity H-imipramine binding in platelets of enuretic children and adolescents. Psychiat. Res. 1985; 14: 39–46
   PubMed Web of Science ®Google Scholar
• Weizman R., Carmi M., Tyano S., Rehavi M. Reduced 3H-imipramine binding but unaltered 3H-serotonin uptake in platelets of adolescent enuretics. Psychiat. Res. 1986; 19: 37–42
   PubMed Web of Science ®Google Scholar